MAA (albumin aggregated) Disease Interactions
There is 1 disease interaction with MAA (albumin aggregated):
Technetium Tc 99m albumin aggregated (applies to MAA) pulmonary heart disease
Major Potential Hazard, High plausibility. Applicable conditions: Pulmonary Heart or Vascular Disease
The use of Technetium Tc 99m albumin aggregated injection is contraindicated in patients with severe pulmonary hypertension. There have been reports of death following its administration to patients with preexisting severe pulmonary hypertension; however, a causal relationship has not been established. Instances of hemodynamic or idiosyncratic reactions to preparations of Technetium Tc 99m albumin aggregated have been reported. Moreover, the intravenous administration of any particulate material such as albumin aggregated imposes a temporary, small mechanical impediment to blood flow. While this effect is expected to be physiologically insignificant in most patients, administration is possibly hazardous in acute cor pulmonale and other states of severely impaired pulmonary blood flow. The use of Technetium Tc 99m albumin aggregated injection should be approached with caution in such patients.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.